MEHARRY MEDICAL COLLEGE
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1876-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.mmc.edu
Clinical Trials
14
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
Perceptions of Trauma and Violence Informed Care
- Conditions
- Intimate Partner Violence
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Meharry Medical College
- Target Recruit Count
- 250
- Registration Number
- NCT05844020
- Locations
- 🇺🇸
Meharry Medical College, Nashville, Tennessee, United States
Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD
- Conditions
- Crohn ColitisInflammatory Bowel DiseasesIndeterminate ColitisUlcerative Colitis
- First Posted Date
- 2022-12-23
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Meharry Medical College
- Target Recruit Count
- 230
- Registration Number
- NCT05663671
- Locations
- 🇺🇸
Meharry Medical College, Nashville, Tennessee, United States
Diabetes Medical Nutrition Therapy in Southeastern African American Women
- Conditions
- Type 2 Diabetes
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Meharry Medical College
- Target Recruit Count
- 291
- Registration Number
- NCT04971889
- Locations
- 🇺🇸
Matthew Walker Comprehensive Health Center, Nashville, Tennessee, United States
🇺🇸Meharry Medical College, Nashville, Tennessee, United States
COVID-19 Vaccine Hesitancy Among African Americans
- Conditions
- Vaccine RefusalCovid19Communication
- First Posted Date
- 2021-03-16
- Last Posted Date
- 2022-04-18
- Lead Sponsor
- Meharry Medical College
- Target Recruit Count
- 300
- Registration Number
- NCT04801030
- Locations
- 🇺🇸
Meharry Medical College, Nashville, Tennessee, United States
Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine
- Conditions
- ContraceptionNeonatal Abstinence SyndromeOpioid-use Disorder
- First Posted Date
- 2020-11-02
- Last Posted Date
- 2020-11-02
- Lead Sponsor
- Meharry Medical College
- Target Recruit Count
- 80
- Registration Number
- NCT04611659
- Locations
- 🇺🇸
Meharry Medical College, Nashville, Tennessee, United States
- Prev
- 1
- 2
- 3
- Next
News
Clinical Trial Diversity Crisis: Dr. Karen Winkfield Outlines Solutions for Inclusive Patient Participation
Clinical trial participation faces major barriers, with trial unavailability and lack of physician referrals identified as primary obstacles to patient enrollment in research studies.
Vanderbilt Cancer Expert Emphasizes Community-Centered Approach to Improve Healthcare Access
Dr. Karen Winkfield, Ingram Professor at Vanderbilt, highlights the critical need to recognize healthcare is not one-size-fits-all, especially for underserved communities facing unique access challenges.
Sanofi Invests $18 Million to Boost Diversity in Clinical Trials at Black Medical Schools
Sanofi is investing $18 million over 10 years in three Historically Black Medical Schools (HBMCs) to establish Centers of Excellence for clinical study diversity.